17 April 2025 A Correction to this paper has been published: References Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, et al
There have been no side effects or long-term health problems associated with this treatment
2116-A ULTRASOUND-DERIVED FAT FRACTION (UDFF) AND AUTO-POINT SHEAR WAVE (AUTO-PSWE) ON THE DEEP ABDOMINAL TRANSDUCER (DAX) FOR LIVER FAT QUANTIFICATION AND LIVER FIBROSIS ASSESSMENT - A PROSPECTIVE BIOPSY-CONTROLLED STUDY Georg Semmler 1 , Larissa Nixdorf 2 , Lukas Hartl 1 , Michael Schwarz 3 , Lorenz Balcar 1 , Mathias Jachs 3 , Paula Richwien 2 , Magdalena Mairinger 2 , Daniel M Felsenreich 4 , Benedikt Simbrunner 5 , Julia Jedamzik 2 , Lisa Gensthaler 4 , Felix B Langer 4 , Mattias Mandorfer 5 , Thomas Reiberger 6 , Gerhard Prager 2 and David Josef Maria Bauer 3 , (1)Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, (2)Department of General Surgery, Division of Visceral Surgery, Medical University of Vienna, Vienna, Austria, (3)Medical University of Vienna, (4)Medical Univesity of Vienna, (5)Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, (6)Cemm Research Center for Molecular Medicine of the Austrian Academy of Sciences Background: Ultrasound-derived fat fraction (UDFF) and auto-point shear wave (Auto-pSWE), have emerged as novel techniques for liver steatosis and fibrosis quantification
When combined with ARA-290, a peptide specifically engineered to target inflammation and nerve regeneration, we see a potential "synergy" that could redefine how we look at healing
